House Dems Want Insulin Pricing Info From Lilly, Novo, Sanofi
Two Democrats from the House Energy and Commerce Committee on Wednesday pushed Eli Lilly & Co., Novo Nordisk A/S and Sanofi to justify the price of their insulin products....To view the full article, register now.
Already a subscriber? Click here to view full article